"Im Augenzentrum am St. Franziskus verbinden sich besondere Kompetenzen im Sinne Ihrer Augen. Unser Team ist mit über 30 Ärztinnen und Ärzten eines der größten in der Region. Darum finden Sie bei uns für alle Abschnitte des Auges und alle wichtigen Erkrankungen einen Spezialisten des jeweiligen Fachs. Unter unseren leitenden Ärzten finden sich international anerkannte Forscher, die kontinuierlich die Methoden der Augenheilkunde weiterentwickeln."

During the past decade, Augenabteilung am St. Franziskus-Hospital conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 5 clinical trials were completed, i.e. on average, 38.5% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 5 clinical trials were completed. i.e. 55.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Augenabteilung am St. Franziskus-Hospital" #1 sponsor was "Hoffmann-La Roche" with 6 trials, followed by "St. Franziskus Hospital" with 6 trials sponsored, "Apellis Pharmaceuticals, Inc." with 2 trials sponsored, "Bayer" with 2 trials sponsored and "Boehringer Ingelheim" with 2 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Augenabteilung am St. Franziskus-Hospital" #1 collaborator was "Regeneron Pharmaceuticals" with 1 trials as a collaborator and "University of Leipzig" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Augenabteilung am St. Franziskus-Hospital" are "Uveitis" (6 trials), "Geographic Atrophy" (4 trials), "Diabetic Macular Edema" (2 trials), "Macular Edema" (2 trials) and "Wet Macular Degeneration" (2 trials). Many other conditions were trialed in "Augenabteilung am St. Franziskus-Hospital" in a lesser frequency.

Most popular intervention types in "Augenabteilung am St. Franziskus-Hospital" are "Drug" (16 trials), "Other" (5 trials), "Device" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Sham Procedure" (5 trials), "Faricimab" (4 trials), "Aflibercept" (2 trials), "Lampalizumab" (2 trials) and "Placebo" (2 trials). Other intervention names were less common.

The vast majority of trials in "Augenabteilung am St. Franziskus-Hospital" are 22 trials for "All" genders.

Currently, there are NaN active trials in "Augenabteilung am St. Franziskus-Hospital". 1 are not yet recruiting, 3 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Augenabteilung am St. Franziskus-Hospital, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Augenabteilung am St. Franziskus-Hospital, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".